PET Scanner Manufacturing
Over the five years to 2018, the PET Scanner Manufacturing industry experienced a marginal decline due to the cyclical nature of this industry. PET scanner purchases are infrequent and represent a significant capital investment for buyers. However, PET scanner utilization among oncologists has remained high because PET scanners are used to diagnose a variety of cancers. The aging baby boomer population's increasing rates of cancer also spurred healthcare providers' use of PET scanners because elderly individuals are at a higher risk of developing cancer compared with young individuals. As elderly individuals continue to account for a larger share of patient volumes, healthcare providers will purchase new PET scanners and update imaging software to help diagnose cancer. Over the five years to 2023, industry revenue is forecast to grow. This growth will be caused by increased order volumes from emerging international markets, an expected price decrease of imaging devices and the continued demand for PET exams for the aging population.
This industry manufactures PET (positron emission tomography) scanners, including combination PET/CT scanners and radiopharmaceuticals. These machines produce 3D images of functional processes in the body and show molecular function and activity, rather than structure, to better differentiate between normal and abnormal tissues.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook